Umar, Rashida MuhammadÇattık, Büşra NurAslan, Selim2023-10-032023-10-032023Umar, R. M., Çattık, B. N. ve Aslan, S. (2023). Evaluation of disease and medication knowledge levels of diabetic patients. İstanbul Journal of Pharmacy, 53(2), 103-109. https://doi.org/10.26650/IstanbulJPharm.2023.11809522587-2087https://doi.org/10.26650/IstanbulJPharm.2023.1180952https://hdl.handle.net/20.500.12511/11518Background and Aims: Diabetes mellitus is a public health problem with a significant economic burden to society. Patient attitude is a significant determinant of adherence and clinical outcomes. We aimed to evaluate the disease and medication knowledge level of diabetic patients and possible patient-related predictive factors. Methods: Adult diabetic patients were included in the study. Patients' demographic and health-related data were collected using a pre-prepared form. Two questionnaires, KAP knowledge tool and Medication Assessment tool were used to assess the disease and medication knowledge levels of patients. Results: The mean age of 159 patients was 54.44 & PLUSMN;12.24 years. The disease and medication knowledge scores were high with an average of 13.9 & PLUSMN;1.74 and 5.26 & PLUSMN;0.53, respectively. Higher scores were linked to being male (p=0.042; p=0.007) and higher educational status (p<0.001; p=0.006). Lower scores were recorded in patients with comorbidities (p=0.002; p<0.001), older patients (p<0.001), longer disease duration (p<0.001; p=0.009), longer antidiabetic drug use (p<0.001; p=0.009) and using more drugs (p=0.002; p=0.006). None of the patients could mention any possible side effects of their medications. Conclusion: It can be deduced that patient-related factors are significant predictors of patients' disease and medication knowledge. Patient-specific education in addition to rational pharmacological intervention is necessary to achieve better clinical outcomes.eninfo:eu-repo/semantics/openAccessDiabetes MellitusDisease KnowledgeMedication KnowledgePatient FactorsArticle53210310910.26650/IstanbulJPharm.2023.1180952N/A001061703800001